SCHEMBL983050

SCHEMBL983050

O=C(CO)N[C@H]1CC[C@H](NC(=O)c2c[nH]c3c(-c4cc(F)ccc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2B Q13224 2/20 0.37
CCNT1 O60563 1/20 0.36
CDK9 P50750 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
HPGD P15428 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CNR1 P21554 3/20 0.34
CRHR1 P34998 2/20 0.34
CRHR2 Q13324 1/20 0.33
TDO2 P48775 1/20 0.33
CNR2 P34972 2/20 0.33
SMYD3 Q9H7B4 1/20 0.33
ABL1 P00519 1/20 0.33
KMO O15229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL984894 0.94 GRIN1 (0.36) GRIN1GRIN2BCCNT1CDK9ALDH1A1
SCHEMBL985885 0.94 GRIN1 (0.36) GRIN1GRIN2BCCNT1CDK9ALDH1A1
SCHEMBL984898 0.93 GRIN1 (0.40) BRD4GRIN1GRIN2BALDH1A1KMT2A
SCHEMBL984334 0.91 BTK (0.39) BRD4GRIN1GRIN2BCCNT1CDK9
SCHEMBL984446 0.91 BTK (0.40) BRD4GRIN1GRIN2BCCNT1CDK9
SCHEMBL985596 0.91 SMYD3 (0.41) BRD4GRIN1GRIN2BALDH1A1KMT2A
Hydrochloric Acid SCHEMBL985170 0.90 SMYD3 (0.40) BRD4GRIN1GRIN2BALDH1A1KMT2A
SCHEMBL981978 0.90 NPY5R (0.38) BRD4GRIN1GRIN2BCCNT1CDK9
SCHEMBL984583 0.90 LMNA (0.38) HPGDNPC1RAB9ALMNA
SCHEMBL983586 0.90 BTK (0.35) GRIN1GRIN2BALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A BRD4 1299/4885GRIN1 2493/4885GRIN2B 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.